Article
Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer
8 Feb 2024
Abstract excerpt
In the realm of cancer therapeutics, targeting the hypoxia-inducible factor (HIF) pathway has emerged as a promising strategy. This study delves into the intricate web of HIF-associated mechanisms, exploring avenues for future anticancer therapies. Framing the investigation within the broader context of cancer progression and hypoxia response, this article aims to decipher the pivotal role played by HIF in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
